Acutaas Chemicals Limited
All news and filings related to Acutaas Chemicals Limited.
View all news & filings- Medium impact
Acutaas Chemicals Granted Process Patent for 2,4-Dimethylthiophenol
Acutaas Chemicals Limited has been granted a 20-year process patent for "A PROCESS FOR PREPARING 2,4-DIMETHYLTHIOPHENOL" by the Indian Patent Office. This marks the company's 11th patent, highlighting its R&D capabilities.
Read the summary - Medium impact
Acutaas Inaugurates New Pilot Plant for R&D and High Potency Intermediate Development
Acutaas Chemicals Limited inaugurated a new pilot plant at its Sachin, Surat facility on September 4, 2026. The plant will support R&D for new product trials and validations, and features OEB 4 containment for developing high potency intermediates used in APIs.
Read the summary - Low impact
Acutaas Chemicals Limited Completes Dispatch of 19th AGM Notice and Annual Report FY26
Acutaas Chemicals Limited has dispatched its 19th AGM notice and FY26 Annual Report. The 19th AGM is scheduled for September 24, 2026. Remote e-voting will be available from September 21 to September 23, 2026. Information is available on the company website and stock exchanges.
Read the summary - Medium impact
Acutaas Chemicals Recommends ₹2.50 Dividend; Tax Deduction Rules Detailed
Acutaas Chemicals recommended a final dividend of ₹2.50 per equity share for FY26. The dividend payout is scheduled for shareholders of record on September 17, 2026, pending approval at the AGM on September 24, 2026. The company detailed tax deduction at source (TDS) rules for resident and non-resident shareholders.
Read the summary - Low impact
Acutaas Chemicals Fixes Sep 17 as Record Date for Final Dividend of 50%
Acutaas Chemicals Limited has set September 17, 2026, as the record date for its final dividend for FY 2025-26. Shareholders are entitled to ₹2.50 per equity share (50% payout). The dividend, if approved at the AGM on September 24, 2026, will be paid within 30 days.
Read the summary - Medium impact
Acutaas Chemicals Announces 19th AGM on Sep 24, 2026; Final Dividend Proposed
Acutaas Chemicals will hold its 19th AGM on September 24, 2026. The company proposes a final dividend of 50% for FY26. Key agenda items include re-appointments of directors Mr. Ram Mohan Lokhande and Mrs. Anita Bandyopadhyay for five-year terms starting Feb 2027. Approval for employee stock options and advancing up to ₹1000 million to subsidiary ACEPL is also sought.
Read the summary - High impact
Acutaas Chemicals Inaugurates Semiconductor Materials Plant in South Korea
Acutaas Chemicals' step-down subsidiary, Indichem Inc., has inaugurated a semiconductor materials plant in Gongju, South Korea. The joint venture, with Acutaas Advance Material Limited holding a 75% stake and investing approximately ₹200 crore, will synthesize chemicals in India and refine them in Korea. The facility was completed in 11 months.
Read the summary - Low impact
Acutaas Chemicals Announces 19th AGM on September 24, 2026
Acutaas Chemicals Limited will hold its 19th Annual General Meeting on September 24, 2026, at 11:30 a.m. IST via Video Conferencing. The company published the notice in newspapers on August 24, 2026. Shareholders are reminded about dividend taxation and TDS compliance.
Read the summary - High impact
Acutaas Chemicals Approves ₹212 Crore Capex Plan, Reappoints Directors
Acutaas Chemicals approved a capital expenditure plan of up to ₹212 crores for a new manufacturing plant in Gujarat. The company re-appointed Mr. Ram Mohan Lokhande as Whole-Time Director and Mrs. Anita Bandyopadhyay as Independent Director for five-year terms starting February 8, 2027. The 19th AGM is scheduled for September 24, 2026.
Read the summary - Medium impact
Acutaas Chemicals gets ECMS incentive approval for Electrolyte Additives business
Acutaas Chemicals Limited received ECMS incentive approval for its Electrolyte Additives business. The company has invested ₹256.47 crore, with ₹119.12 crore eligible for incentives. Benefits up to 25% of eligible investment are expected until FY 2030-31.
Read the summary - Low impact
Acutaas Chemicals to Engage with Investors in Singapore and Mumbai on Aug 12-13
Acutaas Chemicals Limited will engage with investors and analysts at two conferences: the Nuvama 21% India Investor Conference in Singapore on August 12, 2026, and the Equirus India Growth Summit in Mumbai on August 13, 2026. These events will include one-on-one and group meetings.
Read the summary - High impact
Acutaas Chemicals Q1 FY27: Revenue Surges 59.1% to ₹329.7 Cr, Battery & Semiconductor Chemicals Drive Growth
Acutaas Chemicals reported a 59.1% YoY revenue increase to ₹329.7 crore in Q1 FY27. The company commenced commercial supply for its battery chemicals plant and expects strong growth from semiconductor chemicals. Advanced Pharmaceutical Intermediates revenue grew 76.5% YoY to ₹292.7 crore. EBITDA and PAT saw significant increases. Full-year revenue growth is projected at 25%.
Read the summary - Low impact
Acutaas Chemicals Limited Publishes Unaudited Financial Results for Q1 FY27
Acutaas Chemicals Limited announced its unaudited financial results for the quarter ended June 30, 2026. The results were published on July 25, 2026, in accordance with SEBI regulations. Detailed financial information is available on stock exchange and company websites.
Read the summary - Low impact
Acutaas Chemicals: Earnings Call Recording Available Online
Acutaas Chemicals Limited has released the recording of its earnings call held on July 24, 2026. The recording is accessible on the company's website and was made available in compliance with SEBI regulations.
Read the summary - High impact
Acutaas Chemicals Q1 FY27 Revenue Jumps 59.1% YoY to ₹3,297 Million
Acutaas Chemicals reported Q1 FY27 revenue of ₹3,297 million (329.7 crore), a 59.1% YoY increase. EBITDA surged 122.1% to ₹1,131 million (113.1 crore), and PAT rose 70.4% to ₹750 million (75 crore). The company projects 25% revenue growth for the full year with stable margins.
Read the summary - High impact
Acutaas Chemicals Q1 FY27 Revenue Surges 59.1% YoY to ₹329.7 Crore; PAT Up 70.4%
Acutaas Chemicals reported Q1 FY27 results with revenue from operations at ₹329.7 crore, up 59.1% YoY. PAT increased by 70.4% to ₹75 crore. EBITDA surged 122.1% to ₹113.1 crore. The company reaffirmed its full-year revenue growth target of 25%.
Read the summary - Medium impact
Acutaas Chemicals Q1FY27 Consolidated Profit ₹749.93 Crore, Revenue ₹329.67 Crore
Acutaas Chemicals reported consolidated revenue of ₹329.67 crore and profit after tax of ₹74.99 crore for Q1FY27. Standalone profit after tax was ₹75.90 crore. The company's shareholding in a subsidiary diluted to 90% in May 2026. A tax inspection concluded with no expected material impact.
Read the summary - Low impact
Acutaas Chemicals Schedules Q1FY27 Earnings Conference Call for July 24, 2026
Acutaas Chemicals Limited will hold an Earnings Conference Call on Friday, July 24, 2026, at 4:00 PM IST to discuss its Q1FY27 unaudited financial results. The call will feature the Chairman, CFO, and President of Strategy. This is a routine update regarding financial result discussion.
Read the summary - Low impact
Acutaas Chemicals Limited: Confirmation Certificate under SEBI Regulations for Q1 FY27
Acutaas Chemicals Limited submitted a confirmation certificate for the quarter ended June 30, 2026, as per SEBI regulations. No dematerialisation requests were processed during this period, ensuring no changes to security certificates or member registers.
Read the summary - Low impact
Acutaas Chemicals: CGST Anti-Evasion Concludes Search, No Material Financial Impact
Acutaas Chemicals Limited's CGST anti-evasion search concluded on June 23, 2026. The company provided requested documents and stated there is no material impact on its financials or operations. No official document has been issued by the CGST department.
Read the summary - Medium impact
Acutaas Chemicals Faces CGST Search at Sachin Facility
Acutaas Chemicals Limited's Sachin facility and registered office are undergoing inspection/search proceedings initiated by the CGST & CE, Anti-evasion Department, Surat, on June 22, 2026. The company is cooperating fully, and no material impact on financials or operations is reported at present.
Read the summary - Low impact
ACUTAAS Chemicals: Shareholding in ACEPL Reduced to 90% via Preferential Allotment
Acutaas Chemicals' shareholding in its subsidiary, ACEPL, decreased from 100% to 90% on May 19, 2026, after allotting 1,111 equity shares to A.R.Z Pharma Ltd at ₹52,490 per share. The allotment was made on a partly paid-up preferential basis via private placement. The final call of 75% to be called up on or before May 2, 2027. ACEPL will continue to be a subsidiary of Acutaas.
Read the summary - High impact
Acutaas Chemicals Presents Investor Presentation Highlighting FY26 Performance and Growth Strategies
Acutaas Chemicals' investor presentation for FY26 reveals strong performance, with revenue reaching ₹13,394 million and PAT at ₹3,564 million. The company highlights its global leadership in key intermediates and expansion into semiconductor and battery chemicals. Significant capex of over ₹1000 crore is planned for sustainable future growth.
Read the summary - Low impact
Acutaas Chemicals to Participate in Investor Conferences in May-June 2026
Acutaas Chemicals Limited will attend multiple investor conferences from May 27 to June 16, 2026. The company will hold one-on-one and group meetings with investors and analysts in Mumbai, Hong Kong, Singapore, and London.
Read the summary - High impact
Acutaas Chemicals Q4 FY26 Earnings Call Transcript Released
Acutaas Chemicals released its Q4 FY26 earnings call transcript. The company reported FY26 revenue of ₹1,339.4 crore (up 33% YoY) and PAT of ₹356.4 crore. Q4 FY26 revenue was ₹432.8 crore (up 40.3% YoY) with PAT at ₹134.3 crore. The company expects 25% revenue growth in FY27 and aims to maintain similar EBITDA margins.
Read the summary - Medium impact
Acutaas Chemicals Limited Publishes Audited Financial Results for Q4 & FY26
Acutaas Chemicals Limited published its audited financial results for Q4 and FY26 on May 1, 2026. The company also announced a dividend payout of ₹2.50 per share. The announcement also included details on various ongoing legal proceedings and debt recovery processes.
Read the summary - Low impact
Acutaas Chemicals Posts Earnings Call Recording, Available Online
Acutaas Chemicals Limited has released the recording of its earnings call held on April 30, 2026. The recording is available on the company's website for investors. This follows a prior intimation on April 27, 2026.
Read the summary - Medium impact
Acutaas Chemicals Recommends Final Dividend of ₹2.5 per Share for FY26
Acutaas Chemicals Limited recommended a final dividend of ₹2.5 per equity share for FY25-26. This amounts to 50% of the face value and requires shareholder approval at the 19th AGM. Record and payout dates will be announced later.
Read the summary - High impact
Acutaas Chemicals Q4 FY26 PAT Surges 114% to ₹1,343 Million
Acutaas Chemicals reported a strong Q4 FY26 with revenue up 40.3% to ₹4,328 million and PAT surging 114.1% to ₹1,343 million. For FY26, revenue grew 33.0% to ₹13,394 million and PAT more than doubled to ₹3,564 million. The company is confident of achieving 25% revenue growth in FY27.
Read the summary - High impact
Acutaas Chemicals Q4 FY26 Revenue Surges 40.3% YoY to ₹432.8 Crore; PAT Up 114.1%
Acutaas Chemicals reported Q4 FY26 revenue of ₹432.8 crore, up 40.3% YoY, and PAT of ₹134.3 crore, up 114.1% YoY with margins at 31.0%. FY26 revenue was ₹1,339.4 crore (up 33.0% YoY) and PAT was ₹356.4 crore (up 122.2% YoY). The company expects 25% revenue growth in FY27.
Read the summary - Medium impact
Acutaas Chemicals Declares Final Dividend, Approves FY26 Financials & Appoints Cost Auditors
Acutaas Chemicals Limited approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company recommended a final dividend of ₹2.5 per equity share for FY 2025-26. Additionally, cost and internal auditors were appointed for FY 2026-27.
Read the summary - Low impact
Acutaas Chemicals Schedules Q4FY26 Earnings Conference Call for April 30
Acutaas Chemicals Limited will hold an earnings conference call on April 30, 2026, at 5:30 PM IST to discuss its audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026. Management representatives including the Chairman and MD will be present.
Read the summary - Low impact
Acutaas Chemicals Launches 'Saksham Niveshak' Campaign for Shareholders
Acutaas Chemicals launches 'Saksham Niveshak' campaign from April 01 to July 09, 2026. The initiative encourages shareholders to update KYC and claim unclaimed dividends. This is in line with IEPFA and MCA directives to prevent transfer of unclaimed amounts and shares to IEPFA.
Read the summary - Low impact
Acutaas Chemicals Limited Files SEBI Certificate for Q4FY26
Acutaas Chemicals Limited has filed its SEBI compliance certificate for the quarter ended March 31, 2026. The registrar confirmed no dematerialisation requests were processed during the period.
Read the summary - Low impact
Acutaas Chemicals Closes Trading Window from April 1 for Q4/FY26 Audited Results
Acutaas Chemicals will close its trading window from April 1, 2026, for designated persons and connected parties. This is to allow for the consideration of audited financial results for the fourth quarter and fiscal year ending March 31, 2026. The board meeting date for approving results will be announced later.
Read the summary - Low impact
Acutaas Chemicals to attend Investec India Promoter & Founder Conference on March 11, 2026
Acutaas Chemicals Limited will attend the Investec India Promoter & Founder Conference on March 11, 2026, in Mumbai. Company officials will interact with investors and analysts through one-on-one and group meetings.
Read the summary - Low impact
Acutaas Chemicals to Attend Investor Conference Meets on Feb 21 & 24
Acutaas Chemicals Limited will attend the Ombkara Capital Investors Meet on February 21, 2026, and the Kotak Flagship Conference "Chasing Growth 2026" on February 24, 2026. Officials will engage in investor and analyst meetings. No price-sensitive information will be discussed.
Read the summary - Medium impact
Acutaas Chemicals Completes 75% Stake Acquisition in South Korean JV, Indichem Inc.
Acutaas Chemicals Limited completed the acquisition of a 75% stake in South Korean company Indichem Inc. via its subsidiary Acutaas Advance Material Limited. Indichem Inc. operates in the semiconductor chemicals industry. The acquisition is part of Acutaas's expansion strategy into global specialty chemicals. Construction of Indichem's plant is underway.
Read the summary - High impact
Acutaas Chemicals Q3 FY26 Earnings Call Transcript Released
Acutaas Chemicals released its Q3 FY26 earnings call transcript. The company reported strong revenue growth and record margins, with PAT crossing ₹100 crore. Revenue guidance for FY26 was revised up to 30% growth, and EBITDA margin guidance was increased to 32-35%. New initiatives in battery and semiconductor chemicals are progressing.
Read the summary - Low impact
Acutaas Chemicals to Attend JM Financial India Xchange Conference on Feb 5
Acutaas Chemicals Limited will attend the JM Financial India Xchange Conference in Singapore on February 5, 2026. Company officials will interact with investors and analysts through one-on-one meetings and group discussions.
Read the summary - Low impact
Acutaas Chemicals Releases Annual Sustainability Report for FY 2024-25
Acutaas Chemicals Limited has published its Annual Sustainability Report for FY 2024-25. The report details ESG integration and highlights key achievements, including the EcoVadis Platinum Medal. Standalone revenue reached ₹9,898 million (₹989.8 crore), and 15.8 MW of solar capacity was commissioned. The company also achieved ISO 50001 certification at its Sachin unit.
Read the summary - Medium impact
Acutaas Chemicals Q3FY26 Consolidated Revenue at ₹3,978.83 Crore
Acutaas Chemicals reported its Q3FY26 results. Consolidated revenue was ₹3,978.83 Lakhs and total income ₹39,788.25 Lakhs. Nine-month consolidated revenue was ₹93,709.05 Lakhs. Standalone Q3 revenue was ₹39,085.60 Lakhs and total income ₹71,588.00 Lakhs. The company invested ₹130.80 Crore in a South Korean JV.
Read the summary - Medium impact
Acutaas Chemicals Q3 FY26 Results: Net Loss Widens to ₹123.12 Lakhs
Acutaas Chemicals Limited reported a standalone net loss of ₹123.12 lakhs for Q3 FY26, an increase from ₹29.60 lakhs in Q3 FY25. Consolidated net profit after tax rose to ₹36.38 lakhs from ₹47.65 lakhs year-on-year. Total income from operations for the quarter was ₹740.70 lakhs (standalone) and ₹1382.47 lakhs (consolidated).
Read the summary - Low impact
Acutaas Chemicals Releases Earnings Call Recording
Acutaas Chemicals Limited has released the recording of its Earnings Call held on January 28, 2026. The recording is available on the company's website and was disclosed as per SEBI regulations. This follows a previous intimation on January 22, 2026.
Read the summary - High impact
Acutaas Chemicals Q3 FY26 Revenue Jumps 43% YoY to ₹3,932mn, PAT Surges 133.7% to ₹1,062mn
Acutaas Chemicals reported a 43.0% YoY increase in Q3 FY26 revenue to ₹3,932 million (393.2 crore) and a 133.7% YoY surge in PAT to ₹1,062 million (106.2 crore). The company revised its full-year revenue growth guidance to approximately 30% from 25%. Management is scaling battery and semiconductor chemical verticals.
Read the summary - High impact
Acutaas Chemicals Q3 FY26 Revenue Soars 43% to ₹393 Crore, PAT Jumps 133%
Acutaas Chemicals reported a 43% YoY revenue increase to ₹393.2 crore for Q3 FY26. PAT surged 133.7% to ₹106.2 crore. The company revised its revenue growth guidance to ~30% based on strong CDMO ramp-up and specialty chemicals growth. New verticals like battery and semiconductor chemicals are progressing.
Read the summary - Low impact
Acutaas Chemicals Files Unaudited Financial Results for Q3 FY26
Acutaas Chemicals Limited has filed its unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025. The independent auditor's review, conducted by Maheshwari & Co., found no material misstatements. The results comply with SEBI regulations and Indian Accounting Standard 34.
Read the summary - Low impact
Acutaas Chemicals Limited: GST Demand of ₹15.44 Lakhs Dropped by Authorities
Acutaas Chemicals Limited announced that the demand for ₹15.44 lakhs in ineligible Input Tax Credit, along with interest and penalty, has been dropped by the Central GST & Central Excise Appeals Commissionerate, Surat. The order was received on January 27, 2026.
Read the summary - Medium impact
Acutaas Chemicals Schedules Q3FY26 Earnings Conference Call for Jan 28
Acutaas Chemicals Limited will hold an Earnings Conference Call on January 28, 2026, at 5:00 PM IST to discuss Q3FY26 and nine-month results ended December 31, 2025. Management, including the Chairman and CFO, will participate.
Read the summary - Medium impact
Acutaas Chemicals Inaugurates New Manufacturing Block for Battery Chemicals
Acutaas Chemicals Limited inaugurated Phase 1 of a new manufacturing block for electrolyte additives and battery chemicals at its Jhagadia facility on January 19, 2026. This expansion aims to boost production capabilities in the battery chemicals sector.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio